Market Cap 5.38B
Revenue (ttm) 1.61B
Net Income (ttm) 282.33M
EPS (ttm) N/A
PE Ratio 48.35
Forward PE 30.54
Profit Margin 17.53%
Debt to Equity Ratio 0.00
Volume 28,222,000
Avg Vol 30,708,242
Day's Range N/A - N/A
Shares Out 523.92M
Stochastic %K 76%
Beta 0.91
Analysts Sell
Price Target $13.43

Company Profile

UiPath, Inc. provides an automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. It offers the UiPath platform, an integrated enterprise software platform that enables AI agents, robots, people, and models to work together in coordinated workflows. The company's UiPath platform includes the UiPath Maestro process orchestration and process intelligence; UiPath agent bui...

Industry: Software - Infrastructure
Sector: Technology
Phone: 844 432 0455
Address:
One Vanderbilt Avenue, 60th Floor, New York, United States
AlwayswrongOkapi
AlwayswrongOkapi May. 19 at 5:41 AM
$PATH rpa + ai = win and cheaper for businesses vs full ai for task
0 · Reply
short_long
short_long May. 19 at 5:22 AM
$PATH What's the bull case here?
0 · Reply
Basuul
Basuul May. 19 at 5:20 AM
$PATH Trending now. Bought the last few days 6200 shares
0 · Reply
Thricejp1
Thricejp1 May. 19 at 4:59 AM
$PATH lfg
0 · Reply
IdeletedRobinhood
IdeletedRobinhood May. 19 at 4:26 AM
$PATH My DD and bull thesis on $PATH: I beleive UiPath is being valued like a stale RPA company, but will successfully become the enterprise orchestration layer for AI agents, robots, humans, and business systems For UiPath, old-school RPA was the core business RPA (Robotic Process Automation) is like a digital office worker that follows rules and clicks/types through software for you RPA was once extremely exciting because bots could automate repetitive work, but investors started worrying that classic RPA was too rules-based, brittle, and difficult to scale Then AI agents came along and made investors ask, “Why use scripted bots if AI agents can reason through tasks?” That hurt investors’ thoughts on growth at UiPath, and hurt the stock And investors were right - at the time, IMO The main reason PATH is beat down is investors worry classic RPA growth has matured, and that UiPath’s newer AI/agentic automation business has not yet proven it can reaccelerate growth However, AI agents still need governance, approvals, security, audit trails, and execution across messy enterprise systems And that is where UiPath fits… If the market starts viewing PATH as AI infrastructure for real-world business execution instead of “old-school bots”, the stock will rerate “So, this is a high risk startup?” No. Just undervalued, IMO. ($5.54B market cap) UiPath is not a cash-burning startup. It has real revenue, strong margins, and a clean balance sheet FY2026 numbers: FY2026 revenue: $1.611B, up 13% YoY ARR: $1.853B, up 11% YoY Q4 revenue: $481M, up 14% YoY Dollar-based net retention: 107% Cash, cash equivalents, and marketable securities: $1.69B Full-year adjusted free cash flow: $372M *New buyback authorization of $500M* after completing a prior $1B repurchase program FY2027 guidance: FY2027 revenue guide: approximately $1.754B–$1.759B FY2027 ARR guide: approximately $2.051B–$2.056B FY2027 non-GAAP operating income guide: approximately $415M “SaaS companies got killed recently and many are undervalued. Why would you buy this?” Valuation and upside. The company is still growing, but priced for little-to-no growth - with zero re-acceleration of growth priced in IMO However, PATH is a profitable automation company with solid growth, with the market waiting for proof of AI-driven acceleration That shift, more precisely, is RPA to agentic automation The new UiPath is becoming a broader business orchestration and agentic automation platform Instead of just bots clicking buttons, the new model is AI agents understanding the task, UiPath orchestrating the process, robots/APIs executing the work, humans approving when needed, and the whole thing being governed, logged, and secure The reason this matters is because enterprises don’t want random employees pasting sensitive data into ChatGPT or Claude, but they want a controlled platform where AI can be used safely inside approved workflows I see it the opportunity at my workplace as government contractor - who works both onsite at government buildings, and onsite at my employer Aside from more simplistic user AI automations with approved workplace tools like CoPilot, actual agentic AI through the use of today’s tools (ChatGPT, Claude, etc) by employees isn’t welcome in fields with more sensitive data (government, healthcare, security, etc) Now, let’s get to partnerships/collaborations: UiPath has an expanded partnership with Google Cloud, including Google Cloud Marketplace, Vertex AI, Google Workspace integrations, and newer Gemini-related document automation work UiPath announced a collaboration with NVIDIA focused on high-trust AI automation for sensitive workflows like fraud detection and healthcare care management. The integration includes NVIDIA NIM and Nemotron model capabilities UiPath announced work with OpenAI around enterprise agentic automation, including a ChatGPT connector and use of OpenAI models inside UiPath workflows UiPath has integrations around Microsoft’s AI ecosystem, including Azure AI Foundry, Microsoft 365 Copilot, and Copilot Studio UiPath partnered with Snowflake to combine UiPath automation with Snowflake Cortex AI UiPath has also launched support around coding agents, including tools like Claude Code, OpenAI Codex, and other coding-agent ecosystems. The idea is that enterprises can use AI coding agents to build automations, while UiPath handles testing, deployment, governance, and production readiness UiPath does not need one AI model to win. Its best position is being the neutral orchestration layer across many AI models and agents Bear case: RPA is becoming mature. Investors worry UiPath’s core business is no longer high-growth Big tech competition is serious. Microsoft, Salesforce, ServiceNow, Google, OpenAI, and others are all pushing AI workflow automation ARR growth of 11% and DBNRR of 107% are solid, but not enough for the market to price PATH like a hot AI stock My counter is that UiPath may actually become more important because of AI, not less. AI agents are powerful, but enterprises still need security, governance, audit trails, human approvals, compliance, error handling, legacy-system integration, deployment control, and workflow orchestration That is UiPath’s lane Earlier this month, they released on-premises agentic AI for the public sector PATH also recently announced an acquisition of WorkFusion, an AI-agent company focused on financial crime compliance for banks Banks spend heavily on compliance and need secure, auditable automation, so WorkFusion fits UiPath’s bigger thesis of becoming the trusted platform for enterprise AI automation Government and financial sectors are both high-dollar areas where, if executed, Agentic AI can thrive - and PATH’s valuation can benefit explosively I believe the market is underestimating the value of a neutral platform that lets AI agents, software robots, APIs, people, and enterprise systems work together safely The market currently sees UiPath as a slowed-down RPA company, but UiPath is becoming the business orchestration layer for enterprise AI With approximately $1.85B ARR, $1.69B in cash/investments, positive free cash flow, a $500M buyback, and partnerships across Google, NVIDIA, OpenAI, Microsoft, Snowflake, and Salesforce, the company has the resources and ecosystem to make the transition If AI agents become common in enterprises, companies will need a trusted platform to govern and execute their work. UiPath has a good chance of being that platform IMO However, if the AI pivot does not reaccelerate growth, PATH may continue to trade like a mature automation company instead of an AI infrastructure winner However, IMO, PATH’s current valuation already reflects that skepticism - all while the company is still profitable, cash-rich, partnered with major AI players, and positioned directly in the enterprise AI automation trend Extremely high reward, with a decent amount of risk already offset IMO Also, if you like short squeezes, short interest sits at 28.7% with 3.5 days to cover My last three high conviction plays which occupied large amounts of my portfolio were: $ASTS at $2.00 $GRRR at $4.00 $POET at $1.75 This is my next big play I bought 7,000 shares at open this morning at $10.29, and plan on buying another 7,000 if earnings on the 28th happen to drop the stock Not investment advice Thanks for reading 🍻
3 · Reply
Convinvestor
Convinvestor May. 19 at 3:44 AM
$PATH you really cant solve everything with AI. Its too expensive. A mix of different LLMs plus RPA is needed to fully automate an enterprise. Secondly, AI still has significant downsides especially around memory and context. That being said I do believe every single company in the world will either embrace AI deeply into every layer of the organization or die. What wallstreet is missing here is that SaaS companies now have augmented capabilities to develop software faster, probably 100x faster, they are the first and foremost beneficiaries of the technology. UiPath has already pivoted and revamped its whole system embedding AI. CEO said it best, with the same budget companies will mow get more bang for their buck, this is the right approach. Other SaaS businesses like Intuit face true risk from incumbents offering a lower pricepoint, they need to augment their offering significantly and quickly.
0 · Reply
Diiiii
Diiiii May. 19 at 2:47 AM
$PATH Ultimately, no matter how groundbreaking "Claude Code" or "Codex" may be, and how powerful these tools are... Enterprises aren't going to flock to them all at once. There are security and compliance issues. In the context of "agentic AI adapted to enterprises," demand for companies like $PATH remains strong. Moreover, while the momentum of AI infrastructure providers has been so strong that it's almost been forgotten... This year, Jensen Huang boldly declared, "The ChatGPT moment for physical AI has arrived," and everyone's attention was focused on that at the beginning of the year. $PATH has accumulated strong expertise in this area as well. Now that the entire software sector is finally recovering, $PATH seems poised to bounce back particularly strongly.
0 · Reply
elprup
elprup May. 19 at 2:24 AM
$PATH piggy backers n coming longs hold on….bs will be coming in next few days…. and tell everyone u have between 1 share and 50,000 it makes a bigger impression :)
0 · Reply
Jackknife06
Jackknife06 May. 19 at 2:23 AM
$PATH why is Q1 projected growth so low compared to recent quarters?
0 · Reply
WinstonPOTG
WinstonPOTG May. 19 at 1:47 AM
$ASTS $GRRR $PATH $POET Right there with ya I bought RCAT at 2.50 and sold at 13.50. Bought RDW at 5. Buying low doesn’t look good at the time. It looks good months later.
3 · Reply
Latest News on PATH
UiPath call volume above normal and directionally bullish

2026-05-15T18:01:34.000Z - 3 days ago

UiPath call volume above normal and directionally bullish


UiPath price target lowered to $12 from $14 at RBC Capital

2026-05-15T12:47:36.000Z - 3 days ago

UiPath price target lowered to $12 from $14 at RBC Capital


UiPath call volume above normal and directionally bullish

2026-05-14T20:10:49.000Z - 4 days ago

UiPath call volume above normal and directionally bullish


UiPath announces UiPath for Coding Agents

2026-05-12T15:03:04.000Z - 6 days ago

UiPath announces UiPath for Coding Agents


Bullish flow in UiPath with shares up 3.76%

2026-05-07T22:12:20.000Z - 11 days ago

Bullish flow in UiPath with shares up 3.76%


UiPath call volume above normal and directionally bullish

2026-05-04T14:45:10.000Z - 14 days ago

UiPath call volume above normal and directionally bullish


UiPath announces expanded collaboration with Deloitte

2026-04-27T13:42:12.000Z - 21 days ago

UiPath announces expanded collaboration with Deloitte


Moderately bullish activity in UiPath with shares down 1.04%

2026-04-24T15:42:02.000Z - 24 days ago

Moderately bullish activity in UiPath with shares down 1.04%


Moderately bullish activity in UiPath with shares down 7.3%

2026-04-23T18:20:59.000Z - 25 days ago

Moderately bullish activity in UiPath with shares down 7.3%


UiPath call volume above normal and directionally bullish

2026-04-21T16:20:01.000Z - 27 days ago

UiPath call volume above normal and directionally bullish


Mixed options sentiment in UiPath with shares down 0.64%

2026-04-14T17:45:14.000Z - 4 weeks ago

Mixed options sentiment in UiPath with shares down 0.64%


UiPath Transcript: Status update

Apr 6, 2026, 11:30 AM EDT - 6 weeks ago

UiPath Transcript: Status update


Mixed options sentiment in UiPath with shares down 1.31%

2026-03-25T20:45:34.000Z - 7 weeks ago

Mixed options sentiment in UiPath with shares down 1.31%


UiPath announces UiPath Solution for Purchase-to-Pay

2026-03-25T12:56:37.000Z - 7 weeks ago

UiPath announces UiPath Solution for Purchase-to-Pay


UiPath launches agentic AI solutions for fraud prevention

2026-03-25T12:51:58.000Z - 7 weeks ago

UiPath launches agentic AI solutions for fraud prevention


UiPath stock: why sell-off makes sense despite Q4 beat and buyback

Mar 12, 2026, 12:48 PM EDT - 2 months ago

UiPath stock: why sell-off makes sense despite Q4 beat and buyback


UiPath Earnings Call Transcript: Q4 2026

Mar 11, 2026, 5:00 PM EDT - 2 months ago

UiPath Earnings Call Transcript: Q4 2026


UiPath Profit, Revenue Rise as AI Adoption Spreads

Mar 11, 2026, 4:57 PM EDT - 2 months ago

UiPath Profit, Revenue Rise as AI Adoption Spreads


UiPath Transcript: 28th Annual Needham Growth Conference Virtual

Jan 13, 2026, 11:00 AM EST - 4 months ago

UiPath Transcript: 28th Annual Needham Growth Conference Virtual


UiPath Earnings Show Accelerating Growth

Dec 4, 2025, 3:50 PM EST - 5 months ago

UiPath Earnings Show Accelerating Growth


UiPath Stock Soars. It's Looking More Like an AI Winner.

Dec 4, 2025, 10:47 AM EST - 5 months ago

UiPath Stock Soars. It's Looking More Like an AI Winner.


UiPath Earnings Call Transcript: Q3 2026

Dec 3, 2025, 5:00 PM EST - 5 months ago

UiPath Earnings Call Transcript: Q3 2026


UiPath Reports Third Quarter Fiscal 2026 Financial Results

Dec 3, 2025, 4:10 PM EST - 5 months ago

UiPath Reports Third Quarter Fiscal 2026 Financial Results


AlwayswrongOkapi
AlwayswrongOkapi May. 19 at 5:41 AM
$PATH rpa + ai = win and cheaper for businesses vs full ai for task
0 · Reply
short_long
short_long May. 19 at 5:22 AM
$PATH What's the bull case here?
0 · Reply
Basuul
Basuul May. 19 at 5:20 AM
$PATH Trending now. Bought the last few days 6200 shares
0 · Reply
Thricejp1
Thricejp1 May. 19 at 4:59 AM
$PATH lfg
0 · Reply
IdeletedRobinhood
IdeletedRobinhood May. 19 at 4:26 AM
$PATH My DD and bull thesis on $PATH: I beleive UiPath is being valued like a stale RPA company, but will successfully become the enterprise orchestration layer for AI agents, robots, humans, and business systems For UiPath, old-school RPA was the core business RPA (Robotic Process Automation) is like a digital office worker that follows rules and clicks/types through software for you RPA was once extremely exciting because bots could automate repetitive work, but investors started worrying that classic RPA was too rules-based, brittle, and difficult to scale Then AI agents came along and made investors ask, “Why use scripted bots if AI agents can reason through tasks?” That hurt investors’ thoughts on growth at UiPath, and hurt the stock And investors were right - at the time, IMO The main reason PATH is beat down is investors worry classic RPA growth has matured, and that UiPath’s newer AI/agentic automation business has not yet proven it can reaccelerate growth However, AI agents still need governance, approvals, security, audit trails, and execution across messy enterprise systems And that is where UiPath fits… If the market starts viewing PATH as AI infrastructure for real-world business execution instead of “old-school bots”, the stock will rerate “So, this is a high risk startup?” No. Just undervalued, IMO. ($5.54B market cap) UiPath is not a cash-burning startup. It has real revenue, strong margins, and a clean balance sheet FY2026 numbers: FY2026 revenue: $1.611B, up 13% YoY ARR: $1.853B, up 11% YoY Q4 revenue: $481M, up 14% YoY Dollar-based net retention: 107% Cash, cash equivalents, and marketable securities: $1.69B Full-year adjusted free cash flow: $372M *New buyback authorization of $500M* after completing a prior $1B repurchase program FY2027 guidance: FY2027 revenue guide: approximately $1.754B–$1.759B FY2027 ARR guide: approximately $2.051B–$2.056B FY2027 non-GAAP operating income guide: approximately $415M “SaaS companies got killed recently and many are undervalued. Why would you buy this?” Valuation and upside. The company is still growing, but priced for little-to-no growth - with zero re-acceleration of growth priced in IMO However, PATH is a profitable automation company with solid growth, with the market waiting for proof of AI-driven acceleration That shift, more precisely, is RPA to agentic automation The new UiPath is becoming a broader business orchestration and agentic automation platform Instead of just bots clicking buttons, the new model is AI agents understanding the task, UiPath orchestrating the process, robots/APIs executing the work, humans approving when needed, and the whole thing being governed, logged, and secure The reason this matters is because enterprises don’t want random employees pasting sensitive data into ChatGPT or Claude, but they want a controlled platform where AI can be used safely inside approved workflows I see it the opportunity at my workplace as government contractor - who works both onsite at government buildings, and onsite at my employer Aside from more simplistic user AI automations with approved workplace tools like CoPilot, actual agentic AI through the use of today’s tools (ChatGPT, Claude, etc) by employees isn’t welcome in fields with more sensitive data (government, healthcare, security, etc) Now, let’s get to partnerships/collaborations: UiPath has an expanded partnership with Google Cloud, including Google Cloud Marketplace, Vertex AI, Google Workspace integrations, and newer Gemini-related document automation work UiPath announced a collaboration with NVIDIA focused on high-trust AI automation for sensitive workflows like fraud detection and healthcare care management. The integration includes NVIDIA NIM and Nemotron model capabilities UiPath announced work with OpenAI around enterprise agentic automation, including a ChatGPT connector and use of OpenAI models inside UiPath workflows UiPath has integrations around Microsoft’s AI ecosystem, including Azure AI Foundry, Microsoft 365 Copilot, and Copilot Studio UiPath partnered with Snowflake to combine UiPath automation with Snowflake Cortex AI UiPath has also launched support around coding agents, including tools like Claude Code, OpenAI Codex, and other coding-agent ecosystems. The idea is that enterprises can use AI coding agents to build automations, while UiPath handles testing, deployment, governance, and production readiness UiPath does not need one AI model to win. Its best position is being the neutral orchestration layer across many AI models and agents Bear case: RPA is becoming mature. Investors worry UiPath’s core business is no longer high-growth Big tech competition is serious. Microsoft, Salesforce, ServiceNow, Google, OpenAI, and others are all pushing AI workflow automation ARR growth of 11% and DBNRR of 107% are solid, but not enough for the market to price PATH like a hot AI stock My counter is that UiPath may actually become more important because of AI, not less. AI agents are powerful, but enterprises still need security, governance, audit trails, human approvals, compliance, error handling, legacy-system integration, deployment control, and workflow orchestration That is UiPath’s lane Earlier this month, they released on-premises agentic AI for the public sector PATH also recently announced an acquisition of WorkFusion, an AI-agent company focused on financial crime compliance for banks Banks spend heavily on compliance and need secure, auditable automation, so WorkFusion fits UiPath’s bigger thesis of becoming the trusted platform for enterprise AI automation Government and financial sectors are both high-dollar areas where, if executed, Agentic AI can thrive - and PATH’s valuation can benefit explosively I believe the market is underestimating the value of a neutral platform that lets AI agents, software robots, APIs, people, and enterprise systems work together safely The market currently sees UiPath as a slowed-down RPA company, but UiPath is becoming the business orchestration layer for enterprise AI With approximately $1.85B ARR, $1.69B in cash/investments, positive free cash flow, a $500M buyback, and partnerships across Google, NVIDIA, OpenAI, Microsoft, Snowflake, and Salesforce, the company has the resources and ecosystem to make the transition If AI agents become common in enterprises, companies will need a trusted platform to govern and execute their work. UiPath has a good chance of being that platform IMO However, if the AI pivot does not reaccelerate growth, PATH may continue to trade like a mature automation company instead of an AI infrastructure winner However, IMO, PATH’s current valuation already reflects that skepticism - all while the company is still profitable, cash-rich, partnered with major AI players, and positioned directly in the enterprise AI automation trend Extremely high reward, with a decent amount of risk already offset IMO Also, if you like short squeezes, short interest sits at 28.7% with 3.5 days to cover My last three high conviction plays which occupied large amounts of my portfolio were: $ASTS at $2.00 $GRRR at $4.00 $POET at $1.75 This is my next big play I bought 7,000 shares at open this morning at $10.29, and plan on buying another 7,000 if earnings on the 28th happen to drop the stock Not investment advice Thanks for reading 🍻
3 · Reply
Convinvestor
Convinvestor May. 19 at 3:44 AM
$PATH you really cant solve everything with AI. Its too expensive. A mix of different LLMs plus RPA is needed to fully automate an enterprise. Secondly, AI still has significant downsides especially around memory and context. That being said I do believe every single company in the world will either embrace AI deeply into every layer of the organization or die. What wallstreet is missing here is that SaaS companies now have augmented capabilities to develop software faster, probably 100x faster, they are the first and foremost beneficiaries of the technology. UiPath has already pivoted and revamped its whole system embedding AI. CEO said it best, with the same budget companies will mow get more bang for their buck, this is the right approach. Other SaaS businesses like Intuit face true risk from incumbents offering a lower pricepoint, they need to augment their offering significantly and quickly.
0 · Reply
Diiiii
Diiiii May. 19 at 2:47 AM
$PATH Ultimately, no matter how groundbreaking "Claude Code" or "Codex" may be, and how powerful these tools are... Enterprises aren't going to flock to them all at once. There are security and compliance issues. In the context of "agentic AI adapted to enterprises," demand for companies like $PATH remains strong. Moreover, while the momentum of AI infrastructure providers has been so strong that it's almost been forgotten... This year, Jensen Huang boldly declared, "The ChatGPT moment for physical AI has arrived," and everyone's attention was focused on that at the beginning of the year. $PATH has accumulated strong expertise in this area as well. Now that the entire software sector is finally recovering, $PATH seems poised to bounce back particularly strongly.
0 · Reply
elprup
elprup May. 19 at 2:24 AM
$PATH piggy backers n coming longs hold on….bs will be coming in next few days…. and tell everyone u have between 1 share and 50,000 it makes a bigger impression :)
0 · Reply
Jackknife06
Jackknife06 May. 19 at 2:23 AM
$PATH why is Q1 projected growth so low compared to recent quarters?
0 · Reply
WinstonPOTG
WinstonPOTG May. 19 at 1:47 AM
$ASTS $GRRR $PATH $POET Right there with ya I bought RCAT at 2.50 and sold at 13.50. Bought RDW at 5. Buying low doesn’t look good at the time. It looks good months later.
3 · Reply
Bohofireboy123
Bohofireboy123 May. 19 at 1:46 AM
$PATH I mean they will beat guidance, I think that its pretty obvious now that they can manipulate it over the finish line. The question is what does it need to do to actually move the stock?
2 · Reply
Twistylenips
Twistylenips May. 19 at 1:40 AM
0 · Reply
IdeletedRobinhood
IdeletedRobinhood May. 19 at 1:22 AM
$PATH If earnings on the 28th drop the stock I’ll buy 7,000 more I called $ASTS at $2.00 $GRRR at $4.00 And $POET at $1.72 Pretty confident $PATH is my next home run over the next 6-24 months 7,000 shares bought at $10.29 this morning Do your own DD I’ll post mine when I have some time to put together something comprehensive
3 · Reply
ceepo
ceepo May. 19 at 12:12 AM
$PATH $250 a share
4 · Reply
22bama22
22bama22 May. 18 at 11:29 PM
$PATH Above the 200 for the 3ird time recently. Maybe this time she will hold.
0 · Reply
zipperson
zipperson May. 18 at 11:18 PM
$PATH Vanguard and BlackRock are the two largest institutional shareholders, followed by State Street, UBS Group, Morgan Stanley, and Bank of America. As of Dec 2025, 523 institutions held PATH, owning ~59.5% of outstanding shares — up from 57.5% the prior quarter, with 329 buyers vs 130 sellers, a bullish skew. Key takeaways: • Vanguard & BlackRock dominate as passive index holders (as expected for any large-cap) • Senvest Management stands out — it’s an active hedge fund, not just an index player, suggesting conviction bets • 447 hedge funds/institutions had ~$4.47B invested in PATH, with 92 opening new positions and 152 increasing — net positive sentiment
0 · Reply
CPA_
CPA_ May. 18 at 11:10 PM
$PATH we need strong earnings, simple as that. Hopefully Mr Dines working hard
0 · Reply
BlakeCanyon50
BlakeCanyon50 May. 18 at 10:51 PM
$PATH I’ve been a bull for many years, I owned this & PLTR when they were both growing. I trimmed, then lost a bit on this a few years ago. Bought 3,161 shares at $9.47. Hoping WS is done punishing this high earning low debt stock.
0 · Reply
Tlaw888999
Tlaw888999 May. 18 at 10:46 PM
$PATH pay attention to institutional shares paytience
0 · Reply
trumpdisasterprez
trumpdisasterprez May. 18 at 10:42 PM
$TSLA $NVDA $CGNX $PATH $ABBNY "The capital rotation is already beginning to map across the stack. " Who writes these utter horseshit posts?
1 · Reply
Carl2233
Carl2233 May. 18 at 10:31 PM
$PATH Agree with you. I posted that same target a few months ago, and I still stick by it; a year ago I would have said not possible, however, the old market ways are over.
1 · Reply
Carl2233
Carl2233 May. 18 at 10:28 PM
$PATH or break it and rocket into the 20s
1 · Reply